Herbs & Supplements

References

Albertazzi P. A review of non-hormonal options for the relief of menopausal symptoms. Treatments in Endocrinology. 2006;5(2):101-113.

Anon: Oil of evening primrose (OEP) (EPO). In: DerMarderosian A, Beutler JA, eds. Facts and Comparisons: The Review of Natural Products. St. Louis, MO, Facts and Comparisons. August 1997.

Arisaka M, Arisaka O, Yamashiro Y. Fatty acid and prostaglandin metabolism in children with diabetes mellitus. II. The effect of evening primrose oil supplementation on serum fatty acid and plasma prostaglandin levels. Prostaglandins, Leukotrienes and Essential Fatty Acids. 1991;43(3):197-201.

Behan PO, Behan WM, Horrobin D. Effect of high doses of essential fatty acids on the postviral fatigue syndrome. Acta Neurologica Scandinavia. 1990;82(3):209-216.

Belch J, Hill A. Evening primrose oil and evening primrose oil in rheumatologic conditions. American Journal of Clinical Nutrition. 2000;71(1):352S-356S.

Belch JJ, Ho M. Pharmacotherapy of Raynaud's phenomenon. Drugs. 1996;52(5):682-695.

Belch JJ, Shaw B, O'Dowd A, et al. Evening primrose oil (Efamol) in the treatment of Raynaud's phenomenon: a double blind study. Thrombosis and Haemostasis [sic]. 1985;54(2):490-494.

Belury MA. Dietary conjugated linoleic acid in health: physiological effects and mechanisms of action. Annual Review of Nutrition. 2002;22:505-531.

Bendich A. The potential for dietary supplements to reduce premenstrual syndrome (PMS) symptoms. Journal of the American College of Nutrition. 2000;19(1):3-12.

Berth-Jones J, Graham-Brown RA. Placebo-controlled trial of essential fatty acid supplementation in atopic dermatitis. Lancet. 1993;341:1557-1560.

Biagi PL, Bordoni A, Masi M, et al. A long-term study on the use of evening primrose oil (Efamol) in atopic children. Drugs under Experimental and Clinical Research. 1988;14(4):285-290.

Birch AE, Fenner GP, Watkins R, Boyd LC. Antioxidant properties of evening primrose seed extracts. Journal of Agricultural and Food Chemistry. 2001;49(9):4502-4507.

Blommers J, de Lange-De Klerk ES, Kuik DJ, Bezemer PD, Meijer S. Evening primrose oil and fish oil for severe chronic mastalgia: a randomized, double-blind, controlled trial. American Journal of Obstetrics and Gynecology. 2002;187(5):1389-1394.

Boberg M, Vessby B, Selinus I. Effects of dietary supplementation with n-6 and n-3 long-chain polyunsaturated fatty acids on serum lipoproteins and platelet function in hypertriglyceridaemic patients. Acta Medica Scandinavia. 1986;220(2):153-160.

Bordoni A, Biagi PL, Masi M, et al. Evening primrose oil (Efamol) in the treatment of children with atopic eczema. Drugs under Experimental and Clinical Research. 1988;14(4):291-297.

Brown JM, McIntosh MK. Conjugated linoleic acid in humans: regulation of adiposity and insulin sensitivity. Journal of Nutrition. 2003;133(10):3041-3046.

Brush MG, Watson SJ, Horrobin DF, Manku MS. Abnormal essential fatty acid levels in plasma of women with premenstrual syndrome. American Journal of Obstetrics and Gynecology. 1984;150(4):363-366.

Brzeski M, Madhok R, Capell HA. Evening primrose oil in patients with rheumatoid arthritis and side-effects of non-steroidal anti-inflammatory drugs. British Journal of Rheumatology. 1991;30(5):370-372.

Budeiri D, Li Wan Po A, Dornan JC. Is evening primrose oil of value in the treatment of premenstrual syndrome? Controlled Clinical Trials. 1996;17(1):60-68.

Cant A, Shay J, Horrobin DF. The effect of maternal supplementation with linoleic and gamma-linolenic acids on the fat composition and content of human milk: a placebo-controlled trial. Journal of Nutritional Sciences and Vitaminology (Tokyo). 1991;37(6):573-579.

Carroll DG. Nonhormonal therapies for hot flashes in menopause. American Family Physician. 2006;73(3):457-464.

Chaud M, Franchi AM, Gimeno MF, Gimeno AL. Gamma-linolenic acid improves the constancy of contractions in uteri from sprayed rats and is metabolized to prostaglandin E1 but not to bisenoic prostanoids. Prostaglandins. 1988;35(1):95-106.

Chenoy R, Hussain S, Tayob Y, O'Brien PM, Moss MY, Morse PF. Effect of oral gamolenic acid from evening primrose oil on menopausal flushing. British Medical Journal. 1994;308(6927):501-503.

Cheung KL. Management of cyclical mastalgia in oriental women: pioneer experience of using gamolenic acid (Efamast) in Asia. Australia and New Zealand Journal of Surgery. 1999;69(7):492-494.

Darlington LG, Stone TW. Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders. British Journal of Nutrition. 2001;85(3):251-269.

De La Cruz JP, Martin-Romero M, Carmona JA, Villalobos MA, Sanchez de la Cuesta F. Effect of evening primrose oil on platelet aggregation in rabbits fed an atherogenic diet. Thrombosis Research. 1997;87(1):141-149.

De La Cruz JP, Quintero L, Galvez J, Villalobos MA, Sanchez de la Cuesta F. Antioxidant potential of evening primrose oil administration in hyperlipemic rabbits. Life Sciences. 1999;65(5):543-555.

Dines KC, Cameron NE, Cotter MA. Comparison of the effects of evening primrose oil and triglycerides containing gamma-linolenic acid on nerve conduction and blood flow in diabetic rats. Journal of Pharmacology and Experimental Therapeutics. 1995;273(1):49-55.

Dove D, Johnson P. Oral evening primrose oil: its effect on length of pregnancy and selected intrapartum outcomes in low-risk nulliparous women. Journal of Nurse Midwifery. 1999;44(3):320-324.

Ebden P, Bevan C, Banks J, Fennerty A, Walters EH. A study of evening primrose seed oil in atopic asthma. Prostaglandins, Leukotrienes and Essential Fatty Acids. 1989;35(2):69-72.

Endres S, Lorenz R, Loeschke K. Lipid treatment of inflammatory bowel disease. Current Opinion in Clinical Nutrition and Metabolic Care. 1999;2(2):117-120.

Engler MM. Comparative study of diets enriched with evening primrose, black currant, evening primrose or fungal oils on blood pressure and pressor responses in spontaneously hypertensive rats. Prostaglandins, Leukotrienes and Essential Fatty Acids. 1993;49(4):809-814.

Gaby AR. Natural remedies for scleroderma. Alternative Medicine Review. 2006;11(3):188-195.

Gateley CA, Miers M, Mansel RE, Hughes LE. Drug treatments for mastalgia: 17 years experience in the Cardiff Mastalgia Clinic. Journal of the Royal Society of Medicine. 1992;85(1):12-15.

Goodwin PJ, Neelam M, Boyd NF. Cyclical mastopathy: a critical review of therapy. British Journal of Surgery. 1988;75(9):837-844.

Greenfield SM, Green AT, Teare JP, Jenkins AP, Punchard NA, Ainley CC, Thompson RP. A randomized controlled study of evening primrose oil and fish oil in ulcerative colitis. Alimentary Pharmacology and Therapeutics. 1993;7(2):159-166.

Guivernau M, Meza N, Barja P, Roman O. Clinical and experimental study on the long-term effect of dietary gamma-linolenic acid on plasma lipids, platelet aggregation, thromboxane formation, and prostacyclin production. Prostaglandins, Leukotrienes and Essential Fatty Acids. 1994; 51(5):311-316.

Haimov-Kochman R, Hochner-Celnikier D. Hot flashes revisited: pharmacological and herbal options for hot flashes management. What does the evidence tell us? Acta Obstetrica et Gynecologica Scandinavica. 2005;84(10):972-979.

Hardy ML. Herbs of special interest to women. Journal of the American Pharmaceutical Association. 200(2);40:234-242.

Hederos CA, Berg A. Epogam evening primrose oil treatment in atopic dermatitis and asthma. Archive of Disease in Childhood. 1996;75(6):494-497.

Horrobin DF. Essential fatty acid and prostaglandin metabolism in Sjogren's syndrome, systemic sclerosis and rheumatoid arthritis. Scandinavian Journal of Rheumatology Supplement. 1986;61:242-245.

Horrobin DF. Prostaglandin E1: physiological significance and clinical use. Wiener Klinische Wochenschrift. 1988;100(14):471-477.

Horrobin DF. The relationship between schizophrenia and essential fatty acid and eicosanoid metabolism. Prostaglandins, Leukotrienes and Essential Fatty Acids. 1992;46(1):71-77.

Horrobin DF. The role of essential fatty acids and prostaglandins in the premenstrual syndrome. Journal of Reproductive Medicine. 1983;28(7):465-468.

Huntley AL, Ernst E. A systematic review of herbal medicinal products for the treatment of menopausal symptoms. Menopause. 2003;10(5):465-476.

Ingram DM, Hickling C, West L, Mahe LJ, Dunbar PM. A double-blind randomized controlled trial of isoflavones in the treatment of cyclical mastalgia. Breast. 2002;11(2):170-174.

Jantti J, Nikkari T, Solakivi T, Vapaatalo H, Isomaki H. Evening primrose oil in rheumatoid arthritis: changes in serum lipids and fatty acids. Annals of Rheumatic Diseases. 1989;48(2):124-127.

Jantti J, Seppala E, Vapaatalo H, Isomaki H. Evening primrose oil and olive oil in treatment of rheumatoid arthritis. Clinical Rheumatology. 1989;8(2):238-244.

Jellin JM, Gregory P, Batz F, Hitchens K, et al, eds. Pharmacist's Letter/Prescriber's Letter. Natural Medicines Comprehensive Database, 3rd Edition. Stockton CA: Therapeutic Research Facility, 2000.

Jenkins AP, Green AT, Thompson RP. Essential fatty acid supplementation in chronic hepatitis B. Alimentary Pharmacology and Therapeutics. 1996;10(4):665-668.

Khan F, Elherik K, Bolton-Smith C, et al. The effects of dietary fatty acid supplementation on endothelial function and vascular tone in healthy subjects. Cardiovascular Research. 2003;59(4):955-962.

Khoo SK, Munro C, Battistutta D. Evening primrose oil and treatment of premenstrual syndrome. Medical Journal of Australia. 1990;153(4):189-192.

Knorr R, Hamburger M. Quantitative analysis of anti-inflammatory and radical scavenging triterpenoid esters in evening primrose oil. Journal of Agricultural and Food Chemistry. 2004;52(11):3319-3324.

Kokke KH, Morris JA, Lawrenson JG. Oral omega-6 essential fatty acid treatment in contact lens associated dry eye. Contact Lens and Anterior Eye. 2008;31(3):141-146.

Leventhal LJ, Boyce EG, Zurier RB. Treatment of rheumatoid arthritis with gammalinolenic acid. Annals of Internal Medicine. 1993;119(9):867-873.

Low Dog T. Menopause: a review of botanical dietary supplements. American Journal of Medicine. 2005;118(12 Suppl 2):98-108.

The Medicines and Healthcare products Regulatory Agency. Department of Health. United Kingdom. Epogam and Efamast (gamolenic acid) - withdrawal of marketing authorisations [sic]. Available at: http://medicines.mhra.gov.uk/whatsnew/epogam.htm Accessed October 8, 2003.

Menendez JA, Vellon L, Colomer R, Lupu R. Effect of gamma-linolenic acid on the transcriptional activity of the Her-2/neu (erbB-2) oncogene. Journal of the National Cancer Institute. 2005;97(21):1611-1615.

Mills DE, Ward R. Attenuation of psychosocial stress-induced hypertension by gamma-linolenic acid (GLA) administration in rats. Proceedings of the Society of Experimental Biology and Medicine. 1984;176(1):32-37.

Morse NL, Clough PM. A meta-analysis of randomized, placebo-controlled clinical trials of Efamol evening primrose oil in atopic eczema. Where do we go from here in light of more recent discoveries? Current Pharmaceutical Biotechnology. 2006;7(6):503-524.

Morse PF, Horrobin DF, Manku MS, Stewart JC, Allen R, Littlewood S, et al. Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and clinical response. British Journal of Dermatology. 1989;121(1):75-90.

Natural Medicines Comprehensive Database, Online Edition. Pharmacist's Letter/Prescriber's Letter. Stockton CA: Therapeutic Research Facility, 2006. Available at: http://www.pharmacistsletter.com/(S(ulqz3s45omt3ag55um4kj345))/home.aspx?li=1&st=1&cs=&s=ND.

North American Menopause Society. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause. 2004;11(1):11-33.

Oliwiecki S, Burton JL. Evening primrose oil and marine oil in the treatment of psoriasis. Clinical and Experimental Dermatology. 1994;19(2):127-129.

Oxholm P, Manthorpe R, Prause JU, Horrobin D. Patients with primary Sjogren's syndrome treated for two months with evening primrose oil. Scandinavian Journal of Rheumatology. 1986;15(2):103-108.

Philp HA. Hot flashes - a review of the literature on alternative and complementary treatment approaches. Alternative Medicine Review. 2003;8(3):284-302.

Puri BK. The clinical advantages of cold-pressed non-raffinated evening primrose oil over refined preparations. Medical Hypotheses. 2004;62(1):116-118.

Puri BK. The safety of evening primrose oil in epilepsy. Prostaglandins, Leukotrienes and Essential Fatty Acids. 2007;77(2):101-103.

Pye JK, Mansel RE, Hughes LE. Clinical experience of drug treatments for mastalgia. Lancet. 1985;2(8451):373-377.

Qureshi S, Sultan N. Topical nonsteroidal anti-inflammatory drugs versus oil of evening primrose in the treatment of mastalgia. Surgeon. 2005;3(1):7-10.

Rock E, DeMichele A. Nutritional approaches to late toxicities of adjuvant chemotherapy in breast cancer survivors. Journal of Nutrition. 2003;133(11 Suppl 1):3785S-3793S.

Rosolowich V, Saettler E, Szuck B, et al. Mastalgia. Journal of Obstetrics and Gynaecology [sic] in Canada. 2006;28(1):49-57.

Schalin-Karrila M, Mattila L, Jansen CT, Uotila P. Evening primrose oil in the treatment of atopic eczema: effect on clinical status, plasma phospholipid fatty acids and circulating blood prostaglandins. British Journal of Dermatology. 1987;117(1):11-19.

Sebedio JL, Gnaedig S, Chardigny JM. Recent advances in conjugated linoleic acid research. Current Opinion in Clinical Nutrition and Metabolic Care. 1999;2(6):499-506.

Soma M, Manku MS, Horrobin DF. The effects of hydrogenated coconut oil, safflower oil, and evening primrose oil on development of hypertension and sodium handling in spontaneously hypertensive rats. Canadian Journal of Physiology and Pharmacology. 1985;63(4):325-330.

Soulairac A, Naruse G. Prostaglandins E1 and psychopathogeny of schizophrenia. [Article in French] Encephale. 1990;16(5):371-374.

Spinella M. Herbal Medicines and Epilepsy: The Potential for Benefit and Adverse Effects. Epilepsy Behavior. 2001;2(6):524-532.

Srivastava A, Mansel RE, Arvind N, Prasad K, Dhar A, Chabra A. Evidence-based management of Mastalgia: A meta-analysis of randomised [sic] trials. Breast. 2007;16(5):503-512.

Stainforth JM, Layton AM, Goodfield MJ. Clinical aspects of the use of gamma linolenic acid in systemic sclerosis. Acta Derm Venereol. 1996;76(2):144-146.

Stenius-Aarniala B, Aro A, Hakulinen A, Ahola I, Seppala E, Vapaatalo H. Evening primose [sic] oil and fish oil are ineffective as supplementary treatment of bronchial asthma. Annals of Allergy. 1989;62(6):534-537.

Sugano M, Ide T, Ishida T, Yoshida K. Hypocholesterolemic effect of gamma-linolenic acid as evening primrose oil in rats. Annals of Nutrition and Metabolism. 1986;30(5):289-299.

Veale DJ, Torley HI, Richards IM, et al. A double-blind placebo controlled trial of Efamol Marine on skin and joint symptoms of psoriatic arthritis. British Journal of Rheumatology. 1994;33(10):954-958.

Viikari J, Lehtonen A. Effect of primrose oil on serum lipids and blood pressure in hyperlipidemic subjects. International Journal of Clinical Pharmacology and Therapeutic Toxicology. 1986;24(12):668-670.

Warren BS, Devine CM. Herbal Medicines and breast cancer risk. Fact Sheet #53. Cornell University Program on Breast Cancer and Environmental Risk Factors. Revised November 2004. Available at: http://envirocancer.cornell.edu/factsheet/diet/fs53/herbal.pdf. Accessed July 14, 2005.

Warren G, McKendrick M, Peet M. The role of essential fatty acids in chronic fatigue syndrome. A case-controlled study of red-cell membrane essential fatty acids (EFA) and a placebo-controlled treatment study with high dose of EFA. Acta Neurologica Scandinavia. 1999;99(2):112-116.

Wetzig NR. Mastalgia: a 3 year Australian study. Australia and New Zealand Journal of Surgery. 1994;64(5):329-331.

Yoon S, Lee J, Lee S. The therapeutic effect of evening primrose oil in atopic dermatitis patients with dry scaly skin lesions is associated with the normalization of serum gamma-interferon levels. Skin Pharmacology and Applied Skin Physiology. 2002;15(1):20-25.

Last Revised July 18, 2008